Search research articles
Contact Us
Filters
Showing results (21-30 of 339) with videos related to
Page
of 34
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1992
Podophyllotoxin derivatives
M D'Incalci, S Garattini
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1990
Podophyllotoxin derivatives
M D'Incalci, S Garattini
Anti-Cancer Drug Design
|
August 1, 1994
Modulation of transcription factor--DNA interactions by anticancer drugs
M Broggini, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1988
Podophyllotoxin derivatives VP-16 and VM-26
M D'Incalci, S Garattini
Journal of Chromatography
|
June 30, 1989
High-performance liquid chromatographic determination of 5-bromodeoxyuridine in human plasma
P G Montaldo, M D'Incalci
Cancer Treatment Reports
|
December 1, 1986
Antagonism of 5-aza-2'-deoxycytidine antileukemic activity by concomitant treatment with cytarabine
T Colombo, C Rossi, M D'Incalci
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats
T Colombo, M Zucchetti, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers
|
May 9, 2000
DNA topoisomerase II poisons and inhibitors
G Capranico, G Giaccone, M D'Incalci
Analytical Biochemistry
|
November 1, 1979
Gas chromatographic determination of hexamethylmelamine in mouse plasma
M D'Incalci, P Morazzoni, C Pantarotto
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
December 1, 1993
Effects of DNA damaging agents on gene expression in two human cancer cell lines
F Vikhanskaya, M D'Incalci, M Broggini
Page
of 34
Search research articles
Search
Showing results (21-30 of 339) with videos related to
Sort By:
Page
of 34
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1992
Podophyllotoxin derivatives
M D'Incalci, S Garattini
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1990
Podophyllotoxin derivatives
M D'Incalci, S Garattini
Anti-Cancer Drug Design
|
August 1, 1994
Modulation of transcription factor--DNA interactions by anticancer drugs
M Broggini, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1988
Podophyllotoxin derivatives VP-16 and VM-26
M D'Incalci, S Garattini
Journal of Chromatography
|
June 30, 1989
High-performance liquid chromatographic determination of 5-bromodeoxyuridine in human plasma
P G Montaldo, M D'Incalci
Cancer Treatment Reports
|
December 1, 1986
Antagonism of 5-aza-2'-deoxycytidine antileukemic activity by concomitant treatment with cytarabine
T Colombo, C Rossi, M D'Incalci
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats
T Colombo, M Zucchetti, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers
|
May 9, 2000
DNA topoisomerase II poisons and inhibitors
G Capranico, G Giaccone, M D'Incalci
Analytical Biochemistry
|
November 1, 1979
Gas chromatographic determination of hexamethylmelamine in mouse plasma
M D'Incalci, P Morazzoni, C Pantarotto
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
December 1, 1993
Effects of DNA damaging agents on gene expression in two human cancer cell lines
F Vikhanskaya, M D'Incalci, M Broggini
Page
of 34